Advaxia Biologics

Advaxia Attends World Vaccine Congress Europe 2022

From October 11-14, Advaxia’s Qualied Person, Dr. Stefania Di Marco, attended the World Vaccine Congress Europe 2022 in Barcelona, Spain. She was joined by Patrick DePalma, Advaxia’s Global VP of Business Development and Marketing.

Dr. Di Marco presented on 14Oct @ 11:15 on the topic of Viral Vector Vaccine Manufacture:

Viral Vector Vaccines: Adeno Virus Productions

Fully integrated service portfolio for adenovirus vaccines — from development, to manufacturing of pre-clinical and clinical supply.

To learn more about the benefits of working with Advaxia, or to schedule a meeting for an upcoming show please fill out the below form.

Leave a Comment

Your email address will not be published. Required fields are marked *

Skip to content